In their recent article in Annals of Oncology, Arnold et al. suggest that primary tumour side may play a role as a predictive clinical marker for efficacy of systemic antineoplastic treatment in patients with advanced colorectal cancer [1]. We would like to make a few comments and questions to the authors.
http://ift.tt/2fQMXj2
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου